CarD stabilizes mycobacterial open complexes via a two-tiered kinetic mechanism

Jayan Rammohan1, Ana Ruiz Manzano1, Ashley L Garner2

  • 1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, USA.

Nucleic Acids Research
|February 21, 2015
PubMed

Insights

Mycobacterium tuberculosis CarD protein stabilizes RNA polymerase (RNAP) open complexes on ribosomal RNA promoters. This transcriptional regulator uses a concentration-dependent mechanism, influencing RNAP energetics and gene regulation.

Area of Science:

  • Molecular Biology
  • Microbiology
  • Biochemistry

Background:

  • CarD is a crucial transcriptional regulator in mycobacteria.
  • Its precise biological function and mechanism of action remain largely undefined.
  • CarD interacts directly with RNA polymerase (RNAP) holoenzyme promoter complexes.

Purpose of the Study:

  • To investigate the role of Mycobacterium tuberculosis CarD in the energetics of RNAP-promoter complex formation.
  • To elucidate the mechanism by which CarD influences open complex (RPo) formation and stability.
  • To characterize the differential interactions of CarD with RNAP from different bacterial species.

Main Methods:

  • Utilized a fluorescent reporter system to quantify RNAP open complex (RPo) formation in real-time.
  • Analyzed the kinetics and stability of RPo formation on the Mycobacterium tuberculosis rrnAP3 promoter.
  • Investigated the effects of CarD concentration and specific CarD mutants on RPo dynamics.
  • Compared the RPo formation efficiency between Mycobacterium bovis RNAP and Escherichia coli RNAP.

Main Results:

  • Mycobacterium tuberculosis CarD significantly impacts the energetics of RNAP-bound complexes on the rrnAP3 promoter.
  • CarD stabilizes the otherwise unstable open complex (RPo) formed by Mycobacterium bovis RNAP.
  • A two-tiered, concentration-dependent mechanism for CarD action was proposed, involving differential affinities for open and closed complexes.
  • CarD accelerates RPo opening and slows bubble collapse at saturating concentrations.
  • Mutational analysis identified key residues (W85, K90, R25) critical for CarD's function in gene regulation.
  • Escherichia coli RNAP efficiently forms RPo on rrnAP3, unlike M. bovis RNAP, indicating polymerase-specific differences.

Conclusions:

  • CarD acts as a critical stabilizer of RNAP open complexes, particularly for Mycobacterium bovis RNAP.
  • The findings support a concentration-dependent, two-tiered mechanism for CarD's regulatory function.
  • Key residues in CarD are essential for its in vivo gene regulatory activity.
  • Significant differences exist in transcriptional machinery between bacterial genera, exemplified by M. bovis and E. coli RNAP interactions with promoters.

Related Concept Videos

Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
9.5K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.8K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

3.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
155
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
7.0K